AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Zinecard (dexrazoxane for injection) is now indicated for reducing the incidence and severity of cardiomyopathy that is associated with doxorubicin administration in those women with metastatic breast cancer, who have received a cumulative doxorubicin dose of 300 mg / ...